GENSIGHT BIOLOGICS S.A.

GENSIGHT BIOLOGICS S.A.

GENSIGHT BIOLOGICS S.A.

Overview
Date Founded

2012

Headquarters

74, rue du Faubourg Saint-Antoine, Paris, 75012, FRA

Type of Company

Public

Employees (Worldwide)

25

Industries

Biotechnology
Hospitals & Patient Services
Holding Companies
Medical Support Services

Company Description

GenSight Biologics SA is a clinical-stage gene therapy company. It engages in research and development of novel therapies for mitochondrial and neurodegenerative. The company also provides ophthalmology services which develops products to restore eyesight to patients suffering from retinal diseases. GenSight Biologics was founded by Bernard Jacques Alex Gilly, Botond Roska, Jean Bennett, Connie Cepko, Luk H. Vandenberghe, Serge Picaud and Jose-Alain Sahel in 2012 and is headquartered in Paris, France.

Contact Data
Trying to get in touch with decision makers at GENSIGHT BIOLOGICS S.A.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Scientific Co-Founder

Chief Executive Officer & Co-Founder

Scientific Co-Founder

Scientific Co-Founder

Scientific Co-Founder

Scientific Co-Founder

Scientific Founder

Chief Financial Officer

Chief Medical Officer

Chief Technical Officer

Board of Directors

President at Bioleap, Inc. (Florida)

Scientific Co-Founder at GENSIGHT BIOLOGICS S.A.

Chief Executive Officer & Co-Founder at GENSIGHT BIOLOGICS S.A.

Member, Board of Directors at GENSIGHT BIOLOGICS S.A.

Senior Advisor at Abingworth LLP

Partner at Sofinnova Partners SAS

Former Chief Operating Officer at Cellectis SA

Chief Development Officer at Stridebio, Inc.

Senior Vice President & General Manager, European Operations at Horizon Pharmaceutical LLC

Co-Founder & Partner at Medicxi Ventures (Jersey) Ltd.

Paths to GENSIGHT BIOLOGICS S.A.
Potential Connections via
Relationship Science
You
GENSIGHT BIOLOGICS S.A.
Owners & Shareholders
Details Hidden

Amiral Gestion is an active, conviction-based, long-term manager which conducts fundamental analysis of French and European small- and medium-sized listed companies, aiming to invest in companies that they understand and whose value they are able to increase.The firm conducts qualitative and quantitative analyses and manages their equity funds according to their sub-portfolio asset management approach while their flexible fund is managed by a committee that selects the stocks based on their safety margins.Amiral Gestion focuses on companies whose business models they understand. Investment decisions are based on the intrinsic value of these businesses, which they calculate based on including safety margins in their forecasts.They invest in companies whose market value is significantly discounted from the intrinsic value and sell strictly on the basis of valuation.

Details Hidden

Friedland Gestion SAS is a French private company located in Paris, also operating in France, that provides investment advice. It was founded in 2002.

Recent Transactions
Details Hidden

GENSIGHT BIOLOGICS S.A. issued EUR Ordinary Shares

Details Hidden

GENSIGHT BIOLOGICS S.A. raised money in a private placement transaction

Transaction Advisors
Legal Advisor

Advised onGENSIGHT BIOLOGICS S.A. issued EUR Ordinary Shares

Global Coordinator

Advised onGENSIGHT BIOLOGICS S.A. issued EUR Ordinary Shares

Underwriter

Advised onGENSIGHT BIOLOGICS S.A. issued EUR Ordinary Shares

Associate

Advised onGENSIGHT BIOLOGICS S.A. issued EUR Ordinary Shares

Legal Advisor

Advised onGENSIGHT BIOLOGICS S.A. issued EUR Ordinary Shares

Legal Advisor

Advised onGENSIGHT BIOLOGICS S.A. issued EUR Ordinary Shares

Advisors & Consultants
Consultant

Chief Medical Officer at Viridian Therapeutics, Inc.

Key Stats and Financials As of 2020
Market Capitalization
$428M
Total Enterprise Value
$255M
Earnings Per Share
$-1.09
EBITDA
$-30.4M
Total Debt
$16.2M
Total Equity
$12.4M
Net Profit
$-38.2M
Revenue
$4.93M
EBITDAMargin
-615.7%
Enterprise Value / Sales
51.65x
TEVNet Income
-6.67x
Debt TEV
0.06x
Investors
Details Hidden

The Vanguard Group is an American investment management company based in Malvern, Pennsylvania, that manages approximately $3.4 trillion[1] in assets. It is the largest provider of mutual funds and now the second-largest provider of exchange-traded funds (ETFs) in the world after BlackRock, with about $451 billion in ETF assets under management, as of March 2015.[3] It offers mutual funds and other financial products and services to retail and institutional investors in the United States and abroad. Founder and former chairman John C. Bogle is credited with the creation of the first index fund available to individual investors,[4] the popularization of index funds generally,[5] and driving costs down across the mutual fund industry.

Details Hidden

Index Ventures is an active manager which focuses on young information technology and life sciences companies located in Europe, Israel and the US, which have the potential to become global players in their market. The firm typically co-invests with local venture capitalists outside Europe.Index Ventures invests from USD 3 million to USD 20 million, with the possibility of investing smaller amounts in seed rounds, such as USD 300.000 to USD 500.000. It acquires minority stakes (20% on average) and is an active board member. The initial investment focus is on series A and B rounds and the firm also participates in follow-up investments at later stages for companies that successfully execute their business plans.Index generally invests in six to ten new investments a year, holds investments for three to five years and seeks exits through IPOs and trade sales.

Details Hidden

Co-Founder at GENSIGHT BIOLOGICS S.A.

Suppliers
Government of France Holding Companies | Paris, France

Novasep Holding SAS Pharmaceuticals | Lyon, France

Novasep Holding SAS provides manufacturing solutions for the life science industries. Its products include agrochemicals fine chemicals and food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France.

Roche Holding AG Hospitals & Patient Services | Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government. Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $82.6 billion during calendar year 2020. Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's Baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses. Johnson & Johnson's pharmaceutical arm is Janssen Pharmaceutica.

Roche Holding AG Pharmaceuticals - Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by GENSIGHT BIOLOGICS S.A.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of GENSIGHT BIOLOGICS S.A.'s profile does not indicate a business or promotional relationship of any kind between RelSci and GENSIGHT BIOLOGICS S.A..